A
Live / Registered — Registered and renewed (as of 04 Mar 2017)
What this means for you
Registered since 09 Jan 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Jan 2017).
Record
- Serial number
- 78101714
- Registration number
- 3197193
- Mark type
- Design + words
- Filed
- 09 Jan 2002
- Published for opposition
- 08 Apr 2003
- Registered
- 09 Jan 2007
- Next maintenance due
- 09 Jan 2017
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment [ and prevention ] of central nervous system diseases and disorders
Owner
- OTSUKA PHARMACEUTICAL CO., LTD., TOKYO 101-8535, JP
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 09 Jan 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 04 Mar 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Mar 2017 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 04 Mar 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Mar 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jan 2017 — TEAS SECTION 8 & 9 RECEIVED
- 09 Jan 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 May 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 May 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 May 2013 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 03 May 2013 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 24 Apr 2013 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 17 Apr 2013 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 25 Jan 2013 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 25 Jan 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL